Table 3.
Response | |
Complete response | 6 (8%) |
Partial response | 44 (59%) |
Stable disease | 20 (27%) |
Progressive disease | 5 (7%) |
ORR | 67% |
Progression-free survival (PFS) | |
Median | 11 months |
12-month | 47% |
Overall survival (OS) | |
Median | 17 months |
12-month | 57% |
Stage IIIA vs. IIIB | |
Median PFS | 16 vs. 9 months |
Median OS | 19 vs.12 months |
PS 0-1 + WL vs. PS 2 | |
Median PFS | 16 vs.10 months |
Median OS | 19 vs.13 months |